Chloroacetyl chloride → HCID 20554401、化合物

HRID 1106031ノート

反応式

HRID 1106031 の反応式
[Cl:1][CH2:2][C:3](Cl)=[O:4].[CH3:6][N:7]1[C:13]2[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=2[NH:11][C:10]2[N:18]=[CH:19][N:20]=[CH:21][C:9]=2[C:8]1=[O:22]>O1CCOCC1.N1C=CC=CC=1>[Cl:1][CH2:2][C:3]([N:11]1[C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=2[N:7]([CH3:6])[C:8](=[O:22])[C:9]2[CH:21]=[N:20][CH:19]=[N:18][C:10]1=2)=[O:4]

参加物

5

実験手順

6.25 g (0.044 mol) of chloroacetyl chloride in 15 ml of absolute dioxan and 4.4 ml of dry pyridine in 15 ml of dioxan are added dropwise simultaneously (at 80° C. and in the course of 20 minutes) to a suspension of 4.6 g (0.020 mol) of 6-methyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one in 35 ml of absolute dioxan. The mixture is heated at the boil for a further 15 minutes and is then allowed to cool. The supernatant liquid is decanted off from the heavy dark phase, and the latter is washed with methylene chloride; the dioxan and methylene chloride phases are concentrated in vacuo. The oil which remains is dissolved in a little chloroform and filtered through neutral silica gel; the filtrate is evaporated and the residue is recrystallized from isopropanol, yield: 2.8 g, m.p. 176° to 178° C. (dec.).

後処理

  1. temperatureThe mixture is heated at the boil for a further 15 minutes
  2. temperatureto cool
  3. customThe supernatant liquid is decanted off from the heavy dark phase
  4. washthe latter is washed with methylene chloride
  5. concentrationthe dioxan and methylene chloride phases are concentrated in vacuo
  6. dissolutionThe oil which remains is dissolved in a little chloroform
  7. filtrationfiltered through neutral silica gel
  8. customthe filtrate is evaporated
  9. customthe residue is recrystallized from isopropanol, yield: 2.8 g, m.p. 176° to 178° C. (dec.)

出典と根拠

ORDレコード
ord-67b563c655d4460d91d14064a35be7de
出典データセット
uspto-grants-1982_01
特許番号
US04311700

反応ノート

読み込み中…